Previous
Poster Home
Next
Real-World Duration of Venetoclax Treatment for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia (CLL/SLL)
07:30am - 03:45pm EDT - April 1, 2023
Information
Resources
Play Recording
https://jnccn.org/view/journal...
Author(s):
Dr. Anna Teschemaker, PhD
, Associate Director, Oncology Outcomes Research, AstraZeneca Pharmaceuticals, LP
Tags:
Outcomes and Health Services Research
Display Label
Action
120-General Poster Session
Download Handout